Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, and Liver Diseases and Immunity.
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming
Systematic review and meta-analysis: Comparing hepatocellular and cholestatic patterns of drug-induced liver injury
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes
Meta‐analysis: hepatitis B reactivation in patients receiving biological therapy
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
FibroGENE: A gene-based model for staging liver fibrosis
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study
Duodenal eosinophilia and early satiety in functional dyspepsia: Confirmation of a positive association in an <scp>A</scp>ustralian cohort
Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
Systematic review with meta‐analysis: clinical manifestations and management of autoimmune hepatitis in the elderly
Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease
Heterogeneity of fibrosis patterns in non‐alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways
Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection
Eradicating hepatitis <scp>C</scp> virus ameliorates insulin resistance without change in adipose depots